title: [Primary amenorrhea revealing micropolycystic ovary syndrome].
abstract: Nine patients with polycystic ovary syndrome revealed by primary amenorrhea were studied clinically, biochemically and ultrasonographically. One of them had excess weight, four had hirsutism and five acne. Testosterone and delta 4-androstenedione levels were high in all patients. Luteinizing hormone (LH) basal levels were increased in five patients. Basal values of follicle-stimulating hormone (FSH) remained within normal range. The LH to FSH ratio was elevated (over 2) in six patients. The LSH response to gonadotropin-releasing hormone (GnRH) was explosive in all patients. Ultrasonography showed that three out of five patients had enlarged ovaries with multiple follicles not exceeding 8 mm. Following treatment, two patients had children after ovulation was induced with clomiphene citrate, one patient became pregnant spontaneously but thereafter opted for voluntary interruption; two patients are still on ovulation-inducing therapy; four patients still have contraception. These results indicate the clinical heterogeneity and the diagnostic problems that surround this uncommon form of a frequently observed disease.
authors.affiliation: Unité d'Endocrinologie et Maladies métaboliques, Médecine B, Hôpital, Bretonneau, Tours.
authors.forename: L
authors.initials: L
authors.lastname: Nduwayo
authors.forename: F
authors.initials: F
authors.lastname: Despert
authors.forename: C
authors.initials: C
authors.lastname: Lecomte
authors.forename: P
authors.initials: P
authors.lastname: Lecomte
mesh_terms: D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000209:etiology*; D000735:Androstenedione / Q000032:analysis; D002996:Clomiphene / Q000627:therapeutic use; D045166:Estradiol Congeners / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis; D005500:Follow-Up Studies; D006801:Humans; D007986:Luteinizing Hormone / Q000032:analysis; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D011247:Pregnancy; D045167:Progesterone Congeners / Q000627:therapeutic use; D013739:Testosterone / Q000032:analysis; D014463:Ultrasonography
chemical_list: D045166:Estradiol Congeners; D045167:Progesterone Congeners; D002996:Clomiphene; D013739:Testosterone; D000735:Androstenedione; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone